Cargando…
The Protective Role of GMI, an Immunomodulatory Protein From Ganoderma microsporum, on 5-Fluorouracil-Induced Oral and Intestinal Mucositis
5-Fluorouracil (5-FU) is used in the treatment of head and neck cancer patients. However, adverse effects experienced such as mucositis and poor appetite may lead to interruption in chemotherapy. The aim of this study is to evaluate the efficacy of GMI, one fungal immunomodulatory protein found in G...
Autores principales: | Li, Che-Hsing, Ko, Jiunn-Liang, Ou, Chu-Chyn, Lin, Wea-Lung, Yen, Cheng-Chieh, Hsu, Chih-Ting, Hsiao, Yu-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423674/ https://www.ncbi.nlm.nih.gov/pubmed/30879354 http://dx.doi.org/10.1177/1534735419833795 |
Ejemplares similares
-
CD133 inhibition via autophagic degradation in pemetrexed-resistant lung cancer cells by GMI, a fungal immunomodulatory protein from Ganoderma microsporum
por: Hsin, I-Lun, et al.
Publicado: (2020) -
GMI, an Immunomodulatory Peptide from Ganoderma microsporum, Restrains Periprosthetic Joint Infections via Modulating the Functions of Myeloid-Derived Suppressor Cells and Effector T Cells
por: Peng, Kuo-Ti, et al.
Publicado: (2021) -
Ganoderma microsporum immunomodulatory protein, GMI, promotes C2C12 myoblast differentiation in vitro via upregulation of Tid1 and STAT3 acetylation
por: Teo, Wan-Huai, et al.
Publicado: (2020) -
Efficacy of GMI, a fungal immunomodulatory protein, for head and neck cancer patients with chemotherapy-related oral mucositis: An open-labeled prospective single-arm study
por: Lu, Hsueh-Ju, et al.
Publicado: (2022) -
GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus
por: Yeh, Hsin, et al.
Publicado: (2022)